Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Polycystic Ovary Syndrome Treatment Using DLBS3233, Metformin, and Combination of Both, and Its Relation to Fertility

NCT01999686 is registered in ClinicalTrials.gov with Dexa Medica Group as lead sponsor.

NCT NCT01999686
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01999686 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Polycystic Ovary Syndrome Treatment Using DLBS3233, Metformin, and Combination of Both, and Its Relation to Fertility
Lead sponsor
Dexa Medica Group
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2014
Completion date
May 31, 2019
Enrollment
186 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

insulin resistance, polycystic ovary syndrome (pcos)